Key facts
- It has raised $186.7M across 5 recorded rounds; the latest was Later Stage VC ($235.0M) in Jan 2022.
- Lyra Health has filed 7 Form Ds with the SEC since 2018, most recently Jan 2022 ($235.0M sold to 4 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Lyra Health
Create free account
No card required
Funding rounds
5 roundsJan 2021Later Stage VC (Series E)$186.7M▮
About Lyra Health
- Industry
- Other Healthcare Services
PA Mark — not yet priced
Lyra Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Lyra Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Lyra Health in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.